Voleon Capital Management LP Gilead Sciences, Inc. Transaction History
Voleon Capital Management LP
- $1.28 Trillion
- Q1 2025
A detailed history of Voleon Capital Management LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Voleon Capital Management LP holds 22,334 shares of GILD stock, worth $2.67 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
22,334
Previous 56,354
60.37%
Holding current value
$2.67 Million
Previous $5.21 Billion
51.92%
% of portfolio
0.2%
Previous 0.39%
Shares
6 transactions
Others Institutions Holding GILD
# of Institutions
2,297Shares Held
1BCall Options Held
9.56MPut Options Held
9.96M-
Black Rock Inc. New York, NY121MShares$14.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$14 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$7.11 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.52 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.39 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $150B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...